Dr. Lal Path Labs Ltd. has informed the Exchange regarding a press release dated January 30, 2026, titled "Press Release on the Un-audited Financial Results (Consolidated and Standalone) for the Quarter & Nine Months ended December 31, 2025".
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has shared a press release dated January 30, 2026, with the stock exchange about its unaudited financial results for the third quarter and nine months ending December 31, 2025. The filing covers both consolidated and standalone numbers. No specific figures are mentioned in this brief filing note itself, as it simply references the attached press release for the detailed financial data. Investors will need to look at the actual press release to see revenue, profit, and growth metrics for the quarter.
This is a routine quarterly results disclosure filing and is not a new business event. The actual stock impact will depend on the numbers revealed in the detailed press release, particularly any growth in revenue and profits versus the same quarter last year and market expectations.